Lupin Limited has informed the Exchange regarding a press release dated February 02, 2026, titled "Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases".
Lupin Limited Press Release Feb 02 2026
Filed with NSE · · 3 pages · English
Watch Lupin's latest callLupin (NSE:LUPIN) Q2 2027 Earnings Call · Replay · Nov 4Read the transcript of Lupin (NSE:LUPIN) Q2 2027 Earnings CallRelease
Earlier from Lupin
- Press Release Jan 23 2026
- Press Release Jan 21 2026
- Press Release Dec 29 2025
- Press Release Dec 18 2025
- Press Release Dec 17 2025
Later from Lupin
- Lupin Launches Dasatinib Tablets in the United States
- Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Security
- Lupin Launches Topiramate Extended-Release Capsules in the United States
- Press Release Feb 04 2026
- 'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin